Cargando…

The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment

Objective: Non-thyroidal complication of high-dose radioiodine therapy for thyroid carcinoma might cause salivary and lacrimal gland dysfunction, which may be transient or permanent in a dose-dependent manner. However, radiation retinopathy complicating 131I therapy, has not been previously well cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaçar Güveli, Tülay, Özkan, Sezer, Öner Tamam, Müge, Uyanık, Ercan, Ediz, Nurcan, Mülazımoğlu, Mehmet, Özpaçacı, Tevfik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288228/
https://www.ncbi.nlm.nih.gov/pubmed/25541931
http://dx.doi.org/10.4274/mirt.33042
_version_ 1782351935605571584
author Kaçar Güveli, Tülay
Özkan, Sezer
Öner Tamam, Müge
Uyanık, Ercan
Ediz, Nurcan
Mülazımoğlu, Mehmet
Özpaçacı, Tevfik
author_facet Kaçar Güveli, Tülay
Özkan, Sezer
Öner Tamam, Müge
Uyanık, Ercan
Ediz, Nurcan
Mülazımoğlu, Mehmet
Özpaçacı, Tevfik
author_sort Kaçar Güveli, Tülay
collection PubMed
description Objective: Non-thyroidal complication of high-dose radioiodine therapy for thyroid carcinoma might cause salivary and lacrimal gland dysfunction, which may be transient or permanent in a dose-dependent manner. However, radiation retinopathy complicating 131I therapy, has not been previously well characterized. The aim of this study was to evaluate the extent of retinal damage among patients who had received high doses of radioiodine treatment. Methods: Forty eyes of 20 patients (3 male, 17 female) who received 250-1000 mCi during 131I therapy and on ophthalmological follow up for a year after the last treatment were included in the study. Mean age of the study group was 50 years (range 25-70 years). In ophthalmologic examination, visual acuity was measured in order to determine visual loss. Intraocular pressure was measured in all the patients. Then lens examination was carried out with slit lamp biomicroscopy in order to investigate cataract or partial lens opacities. Fundus observation was carried out through the dilated pupil with slit lamp biomicroscopy using 90 D noncontact lens. Result: The best corrected visual aquity with Snellen chart was found as 1.0 in 36 eyes (90%) and between 0.6 and 0.9 (10%) in 4 eyes (10%). At the biomicroscopic fundus examination, retinal hemorrhage consistent with radiation retinopathy, microaneurysm, microinfarction, edema or exudation, vitreus hemorrhage, partial or total optical disc pallor indicating papillopathy in the optic disc were not observed in any of the eyes. Conclusion: This result indicates that there is not any significant correlation between repeated high-dose radioiodine therapy and radiation retinopathy in differentiated thyroid carcinomas. Even though there is not a significant restriction in use of higher doses of radioiodine therapy in differentiated thyroid carcinoma, more extensive studies are needed in order to obtain more accurate data on possible occurrence of retinopathy.
format Online
Article
Text
id pubmed-4288228
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-42882282015-01-21 The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment Kaçar Güveli, Tülay Özkan, Sezer Öner Tamam, Müge Uyanık, Ercan Ediz, Nurcan Mülazımoğlu, Mehmet Özpaçacı, Tevfik Mol Imaging Radionucl Ther Original Article Objective: Non-thyroidal complication of high-dose radioiodine therapy for thyroid carcinoma might cause salivary and lacrimal gland dysfunction, which may be transient or permanent in a dose-dependent manner. However, radiation retinopathy complicating 131I therapy, has not been previously well characterized. The aim of this study was to evaluate the extent of retinal damage among patients who had received high doses of radioiodine treatment. Methods: Forty eyes of 20 patients (3 male, 17 female) who received 250-1000 mCi during 131I therapy and on ophthalmological follow up for a year after the last treatment were included in the study. Mean age of the study group was 50 years (range 25-70 years). In ophthalmologic examination, visual acuity was measured in order to determine visual loss. Intraocular pressure was measured in all the patients. Then lens examination was carried out with slit lamp biomicroscopy in order to investigate cataract or partial lens opacities. Fundus observation was carried out through the dilated pupil with slit lamp biomicroscopy using 90 D noncontact lens. Result: The best corrected visual aquity with Snellen chart was found as 1.0 in 36 eyes (90%) and between 0.6 and 0.9 (10%) in 4 eyes (10%). At the biomicroscopic fundus examination, retinal hemorrhage consistent with radiation retinopathy, microaneurysm, microinfarction, edema or exudation, vitreus hemorrhage, partial or total optical disc pallor indicating papillopathy in the optic disc were not observed in any of the eyes. Conclusion: This result indicates that there is not any significant correlation between repeated high-dose radioiodine therapy and radiation retinopathy in differentiated thyroid carcinomas. Even though there is not a significant restriction in use of higher doses of radioiodine therapy in differentiated thyroid carcinoma, more extensive studies are needed in order to obtain more accurate data on possible occurrence of retinopathy. Galenos Publishing 2014-10 2014-10-05 /pmc/articles/PMC4288228/ /pubmed/25541931 http://dx.doi.org/10.4274/mirt.33042 Text en © Molecular Imaging and Radionuclide Therapy, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kaçar Güveli, Tülay
Özkan, Sezer
Öner Tamam, Müge
Uyanık, Ercan
Ediz, Nurcan
Mülazımoğlu, Mehmet
Özpaçacı, Tevfik
The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
title The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
title_full The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
title_fullStr The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
title_full_unstemmed The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
title_short The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
title_sort effect of high dose radioiodine therapy on formation of radiation retinopathy during thyroid cancer treatment
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288228/
https://www.ncbi.nlm.nih.gov/pubmed/25541931
http://dx.doi.org/10.4274/mirt.33042
work_keys_str_mv AT kacarguvelitulay theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT ozkansezer theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT onertamammuge theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT uyanıkercan theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT ediznurcan theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT mulazımoglumehmet theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT ozpacacıtevfik theeffectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT kacarguvelitulay effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT ozkansezer effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT onertamammuge effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT uyanıkercan effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT ediznurcan effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT mulazımoglumehmet effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment
AT ozpacacıtevfik effectofhighdoseradioiodinetherapyonformationofradiationretinopathyduringthyroidcancertreatment